TY - JOUR
T1 - World Workshop on Oral Medicine VII
T2 - Burning mouth syndrome: A systematic review of disease definitions and diagnostic criteria utilized in randomized clinical trials
AU - Ariyawardana, Anura
AU - Chmieliauskaite, Milda
AU - Farag, Arwa M.
AU - Albuquerque, Rui
AU - Forssell, Heli
AU - Nasri-Heir, Cibele
AU - Klasser, Gary D.
AU - Sardella, Andrea
AU - Mignogna, Michele D.
AU - Ingram, Mark
AU - Carlson, Charles R.
AU - Miller, Craig S.
N1 - Publisher Copyright:
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. All rights reserved
PY - 2019/6
Y1 - 2019/6
N2 - Objective: To conduct a systematic review analyzing disease definitions and diagnostic criteria used in randomized controlled trials (RCTs) involving burning mouth syndrome (BMS). Methods: A systematic search conducted in PubMed, Web of Science, PsycINFO, Cochrane Database/Cochrane Central, and Google Scholar that included RCTs on BMS published between 1994 and 2017 was performed. Results: Considerable variability in BMS disease definitions and diagnostic criteria used created substantial heterogeneity in the selection of participants and weakened the rigor of the 36 RCTs identified. The analyzed RCTs routinely under-reported the methods used to rule in or out study participants and the number of individuals excluded from BMS RCTs. Conclusions: Our findings indicate that a large proportion of participants enrolled in these studies may have had an underlying condition that could have explained their BMS symptoms. Thus, outcomes of therapeutic interventions from these BMS RCTs should be interpreted with caution due to heterogeneous disease definitions and diagnostic criteria. In order to improve the quality of clinical trials, future research should focus on establishing consensus for a single definition of BMS that includes specific inclusion and exclusion criteria that should be used to select study participants for clinical trials.
AB - Objective: To conduct a systematic review analyzing disease definitions and diagnostic criteria used in randomized controlled trials (RCTs) involving burning mouth syndrome (BMS). Methods: A systematic search conducted in PubMed, Web of Science, PsycINFO, Cochrane Database/Cochrane Central, and Google Scholar that included RCTs on BMS published between 1994 and 2017 was performed. Results: Considerable variability in BMS disease definitions and diagnostic criteria used created substantial heterogeneity in the selection of participants and weakened the rigor of the 36 RCTs identified. The analyzed RCTs routinely under-reported the methods used to rule in or out study participants and the number of individuals excluded from BMS RCTs. Conclusions: Our findings indicate that a large proportion of participants enrolled in these studies may have had an underlying condition that could have explained their BMS symptoms. Thus, outcomes of therapeutic interventions from these BMS RCTs should be interpreted with caution due to heterogeneous disease definitions and diagnostic criteria. In order to improve the quality of clinical trials, future research should focus on establishing consensus for a single definition of BMS that includes specific inclusion and exclusion criteria that should be used to select study participants for clinical trials.
KW - burning mouth syndrome
KW - clinical trials
KW - diagnosis
KW - disease classification
UR - http://www.scopus.com/inward/record.url?scp=85066409289&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066409289&partnerID=8YFLogxK
U2 - 10.1111/odi.13067
DO - 10.1111/odi.13067
M3 - Review article
C2 - 30785661
AN - SCOPUS:85066409289
SN - 1354-523X
VL - 25
SP - 141
EP - 156
JO - Oral Diseases
JF - Oral Diseases
IS - S1
ER -